Moody’s Upgrades Smith & Nephew (SNN) Long-Term Rating, Citing Strong Revenue and Margin Growth
Smith & Nephew plc (NYSE:SNN) ranks among the best medical device stocks to invest in. Moody’s Ratings upgraded Smith & Nephew plc (NYSE:SNN)’s Baa2 long-term issuer ratings from stable to positive on October 2. Despite possible concern from US tariffs, the update shows strong organic revenue and margin growth backed by the company’s ongoing transformation plan. The company’s improved free cash flow generation, which has returned to pre-pandemic levels, has improved financial flexibility, according to Mo ...